NYSE$MPT
Medical Properties Trust Inc · Q2 2024 earnings
Q2 2024 earnings · · Investor relations
Briefing
Announced financial results for the second quarter ended June 30, 2024, and executed over $2.5 billion in year-to-date liquidity transactions.
Medical Properties Trust reported a net loss of ($0.54) per share and Normalized Funds from Operations (NFFO) of $0.23 per share for the second quarter of 2024. The company successfully executed more than $2.5 billion in year-to-date liquidity transactions and modified its credit facility terms.
- Closed on the sale of five hospitals to Prime Healthcare for $350 million in April.
- Completed a £631 million (~$800 million) secured financing of 27 U.K. hospitals leased to Circle Health in May.
- Sold seven freestanding emergency department facilities and one general acute hospital in Arizona to Dignity Health for approximately $160 million in July.
- Repaid approximately $1.5 billion in debt, including all 2024 maturities.
Headline financials
Revenue & EPS history
Medical Properties Trust · Revenue · Quarterly
$267M
Revenue by segment
Medical Properties Trust · $307M total across 4 segments · Q3 2023
- Rent Billed$229M-1.3%74.8%
- Interest and Other Income$29.7M-29.9%9.7%
- Income from Financing Leases$26.1M-48.9%8.5%
- Straight-line Rent$21.5M-19.0%7.0%
Forward guidance
MPT amended its credit facility to reflect recent disposition and financing transactions and better align with the Company’s current capital allocation strategy.
Tailwinds
- Reduction of MPT’s revolver commitment from $1.4 billion to $1.28 billion.
- Permanent resetting of the facility’s consolidated net worth covenant from approximately $6.7 billion to $5.0 billion.
- Modifications to certain other covenants through September 30, 2025.
- MPT has agreed to limit the cash component of total quarterly dividends to no more than $0.08 per share.
- Company has the right to terminate the amendment provisions earlier than September 30, 2025, if Steward’s hospital operations are transitioned to other operators more rapidly.
Headwinds
- Potential impact from health crises which may adversely affect MPT’s and its tenants’ business, financial condition, results of operations and liquidity.
- Risk that previously announced or contemplated property sales, loan repayments, and other capital recycling transactions do not occur as anticipated or at all.
- Risk that MPT is not able to attain its leverage, liquidity and cost of capital objectives within a reasonable time period or at all.
- MPT’s ability to obtain debt financing on attractive terms or at all, as a result of changes in interest rates and other factors, which may adversely impact its ability to pay down, refinance, restructure or extend its indebtedness as it becomes due, or pursue acquisition and development opportunities.
- Risk that the bankruptcy restructuring of Steward, the Company’s largest tenant, does not result in MPT recovering deferred rent or its other investments in Steward at full value, within a reasonable time period or at all.
Historical earnings impact
How earnings announcements have historically affected this stock's price.
Avg. return before/after earnings
Based on 20 quarterly earnings reports · overlaid with Q2 2024
+1.3%
Avg return
Earnings day
+1.6%
Avg return
5 days after
+0.7%
Avg return
30 days after
65%
42 / 65 earnings
Positive
+17.0%
Q4 2024
Best reaction
-15.8%
Q2 2023
Worst reaction
| Quarter | Report date | Reaction (Day 0) | +5 days | +30 days |
|---|---|---|---|---|
| Q1 2026 | -2.6% | -4.1% | -6.0% | |
| Q4 2025 | +12.1% | +6.1% | -15.1% | |
| Q3 2025 | +6.6% | +1.4% | +18.5% | |
| Q1 2025 | -6.9% | -8.0% | -17.2% | |
| Q4 2024 | +17.0% | +18.2% | +26.6% | |
| Q3 2024 | +7.0% | -5.2% | -9.8% | |
| Q2 2024 | +1.5% | +2.4% | +7.4% | |
| Q1 2024 | +7.2% | +31.2% | +20.4% | |
| Q4 2023 | +2.5% | +6.7% | +13.9% | |
| Q3 2023 | +9.9% | +7.2% | +4.7% | |
| Q2 2023 | -15.8% | -20.0% | -33.4% | |
| Q1 2023 | +10.6% | +4.9% | -0.1% | |
| Q4 2022 | -13.5% | -15.6% | -38.3% | |
| Q3 2022 | +6.8% | +6.5% | +20.6% | |
| Q2 2022 | -5.3% | -4.3% | -15.3% | |
| Q1 2022 | +4.1% | +6.3% | +5.2% | |
| Q4 2021 | -4.0% | -5.2% | -10.2% | |
| Q3 2021 | +0.1% | -1.2% | +1.5% | |
| Q2 2021 | +1.3% | -1.5% | -3.3% | |
| Q1 2021 | -2.0% | -4.1% | -5.9% | |
| Q4 2020 | +0.0% | +1.6% | -2.9% | |
| Q3 2020 | +3.7% | +10.9% | +13.8% | |
| Q2 2020 | -0.8% | -1.6% | -8.5% | |
| Q1 2020 | +4.1% | +0.5% | +9.8% | |
| Q4 2019 | +2.3% | +3.6% | +1.1% | |
| Q3 2019 | +1.2% | -6.8% | +0.9% | |
| Q2 2019 | +2.1% | -0.1% | +6.2% | |
| Q1 2019 | +3.8% | +1.2% | +2.0% | |
| Q4 2018 | +3.4% | +1.7% | +1.1% | |
| Q3 2018 | +3.2% | +9.9% | +16.2% | |
| Q2 2018 | +1.0% | +3.0% | +4.2% | |
| Q1 2018 | +1.8% | +2.0% | +5.6% | |
| Q4 2017 | +1.6% | +1.5% | +6.6% | |
| Q3 2017 | +3.2% | +3.9% | +4.8% | |
| Q2 2017 | -1.7% | +0.1% | +5.2% | |
| Q1 2017 | +2.1% | +2.5% | +4.3% | |
| Q4 2016 | +1.8% | +1.8% | -6.3% | |
| Q3 2016 | -0.8% | +1.3% | -2.7% | |
| Q2 2016 | +1.1% | +2.0% | -0.5% | |
| Q1 2016 | +3.8% | — | — | |
| Q4 2015 | -2.5% | — | — | |
| Q3 2015 | -3.4% | — | — | |
| Q2 2015 | -3.8% | — | — | |
| Q1 2015 | +2.9% | — | — | |
| Q4 2014 | +0.4% | — | — | |
| Q3 2014 | +2.7% | — | — | |
| Q2 2014 | -0.3% | — | — | |
| Q1 2014 | -0.9% | — | — | |
| Q4 2013 | -0.4% | — | — | |
| Q3 2013 | -0.7% | — | — | |
| Q2 2013 | -2.8% | — | — | |
| Q1 2013 | -1.0% | — | — | |
| Q4 2012 | +1.1% | — | — | |
| Q3 2012 | +3.1% | — | — | |
| Q2 2012 | +0.7% | — | — | |
| Q1 2012 | -0.1% | — | — | |
| Q4 2011 | -0.6% | — | — | |
| Q4 2009 | -0.6% | — | — | |
| Q3 2011 | -4.4% | — | — | |
| Q2 2011 | +4.5% | — | — | |
| Q1 2011 | +2.8% | — | — | |
| Q4 2010 | +2.8% | — | — | |
| Q3 2010 | +0.5% | — | — | |
| Q2 2010 | +1.0% | — | — | |
| Q1 2010 | +7.9% | — | — |
Discussion
Share your read of this quarter. Sign-in carries your eToro identity.
Join the conversation
Sign in with eToro to post your read of this quarter and vote on others'.
Sign in with eToro